Shine secures $125M in financing

Medical isotope firm Shine Medical Technologies has won $125 million in debt and equity financing with Deerfield Management of New York City.

Under terms of the agreement, Deerfield Management will distribute the financing to Shine in milestone-linked phases. With these funds and $25 million from the U.S. Department of Energy's National Nuclear Security Administration, the company plans to build a new manufacturing plant for molybdenum-99 in Wisconsin and cover operating costs necessary to bring the plant into production.

Page 1 of 435
Next Page